These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 7691773

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G, Schulze HJ, Färber L, Weidinger G, Steigleder GK.
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [Abstract] [Full Text] [Related]

  • 3. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G, Meyer-Hamme S, Ippen H.
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. etretinate (re-TL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients.
    Green C, Lakshmipathi T, Johnson BE, Ferguson J.
    Br J Dermatol; 1992 Jul; 127(1):5-9. PubMed ID: 1637696
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis.
    Lauharanta J, Juvakoski T, Lassus A.
    Br J Dermatol; 1981 Mar; 104(3):325-32. PubMed ID: 7011359
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Etretinate therapy.
    Ellis CN, Voorhees JJ.
    J Am Acad Dermatol; 1987 Feb; 16(2 Pt 1):267-91. PubMed ID: 3546414
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].
    Domínguez Soto L, Hokyo Tomoka MT, Armas JJ.
    Med Cutan Ibero Lat Am; 1984 Feb; 12(1):47-56. PubMed ID: 6376979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.